🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. Dupilumab

    Regeneron UK Limited

    Allergic Contact Dermatitis

    approved small molecule active

    1 trial

  2. Dupilumab

    Regeneron UK Limited

    Dermatitis, Atopic

    approved small molecule active

    5 trials

  3. Dupilumab

    Regeneron UK Limited

    Dermal Hypersensitivity Reaction

    approved small molecule completed

    1 trial

  4. Dupilumab

    Regeneron UK Limited

    Chronic Rhinosinusitis With Nasal Polyps

    approved small molecule completed

    1 trial

  5. Dupilumab

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial

  6. Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]

    Regeneron UK Limited

    Eosinophilic Esophagitis (EoE)

    approved small molecule active

    1 trial

  7. Dupilumab Injectable Product

    Regeneron UK Limited

    Asthma

    approved small molecule active

    1 trial

  8. Dupilumab Only Product

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule active

    1 trial

  9. Dupilumab Prefilled Syringe

    Regeneron UK Limited

    Nasal Polyps

    approved small molecule active

    1 trial

  10. Dupilumab SAR231893

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule completed

    1 trial

  11. Dupilumab SAR231893

    Regeneron UK Limited

    Dermatitis Atopic

    approved small molecule completed

    2 trials

  12. Dupilumab SAR231893

    Regeneron UK Limited

    Chronic Rhinosinusitis With Nasal Polyps

    approved small molecule completed

    1 trial

  13. Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe

    Sanofi-aventis Healthcare Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  14. Dupilumab, matched placebo for test product, Ventolin Evohaler 100 micrograms

    Sanofi-aventis Healthcare Pty Ltd

    Respiratory tract diseases

    approved small molecule active

    1 trial

  15. Durvalumab

    AstraZeneca

    Solid Tumor

    approved small molecule completed

    1 trial

  16. ENZALUTAMIDE, DOCETAXEL, ABIRATERONE

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial

  17. EVOLOCUMAB

    Amgen

    Dyslipidemia

    approved small molecule active

    1 trial

  18. Edoxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Valvular Atrial Fibrillation

    approved small molecule completed

    1 trial

  19. Eliquis 5 mg film-coated tablets, Waran 2,5 mg tabletter, OPTISON 0.19 mg/ml dispersion for injection, SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, Eliquis 2.5 mg film-coated tablets

    The George Institute

    Left ventricular thrombosis., Acute mycocardial infarction (AMI)

    approved small molecule active

    1 trial

  20. Enbrel 25 mg powder and solvent for solution for injection, ADALIMUMAB, ETANERCEPT, Humira 20 mg solution for injection in pre-filled syringe

    Fondazione Telethon ETS

    Juvenile Idiopathic Arthritis

    approved small molecule active

    1 trial

  21. Eufilina Venosa 200 mg solución inyectable, Clariscan 0,5 mmol/mL solución inyectable EFG, Rapiscan 400 microgram solution for injection

    The George Institute

    Coronary artery chronic total occlusion

    approved small molecule active

    1 trial

  22. Exenatide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    approved small molecule active

    1 trial

  23. Exenatide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  24. Eylea 114.3 mg/ml solution for injection

    Bayer AG

    Neovascular age-related macular degeneration (nAMD), Diabetic macular edema (DME)

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources